Grey Wolf Therapeutics

This study is testing a new oral drug, GRWD5769, for people with advanced solid cancers that have spread or returned. The main goal is to see if the drug is safe and tolerable, both by itself and when combined with an existing immunotherapy. Researchers want to see if blocking a …

This study is testing a new oral pill, GRWD0715, to see if it is safe and can help control axial spondyloarthritis (axSpA), a long-term inflammatory disease that mainly affects the spine and pelvis. The pill works by targeting a specific enzyme thought to trigger the harmful immu…